Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
The Pharmaceutical Marketing Group
The Pharmaceutical Marketing Group
PROFESSIONAL EDITION
The largest community of pharma leaders
Subscribe to Our News!
Facebook
Instagram
Linkedin
Pinterest
Twitter
Search
Home
FEATURED
Featured Report
FEATURED WEBINAR
MEET OUR FEATURED WRITERS
NATALIE YEADON
TOMASO SALANITRI
NEWSLETTERS
SUBSCRIBE NOW
NEWS
Make Webinars works for your business
Call For Featured Writers
ABOUT US
Our Agency
Our Services
Our Resources
More
Featured
2019 Authors
Featured Authors
Must Read
Newsletters
Webinars
Natalie Yeadon
Top 10 Tips for Running a Successful Virtual Event
The ways that pharmaceutical and scientific communities attend meetings and events completely changed in 2020. Virtual events are rapidly improving, as are the platforms...
Natalie Yeadon
-
March 25, 2021
0
Read more
Natalie Yeadon
The Zeigarnik Effect – What is it and how can it help increase productivity?
As I discussed in my recent webinar on the power of habit, habits, whether conscious or subconscious, are the cause of about 40-45% of...
Natalie Yeadon
-
January 7, 2020
0
Read more
Recent Articles
StemSynergy Therapeutics’ Notch1-Selective Small Molecule Inhibitor Prevents Tumor Growth by Ablation of Cancer Stem Cells
Industry News
April 15, 2021
Genentech’s Evrysdi Continues to Improve Motor Function and Survival in Babies With Type 1 Spinal Muscular Atrophy (SMA)
Industry News
April 15, 2021
Prestige Biopharma and Pharmapark Announce License and Supply Agreement to Commercialize Prestige's Bevacizumab Biosimilar in the Russian Federation
Industry News
April 15, 2021
Merck and Ridgeback Biotherapeutics Provide Update on Progress of Clinical Development Program for Molnupiravir, an Investigational Oral Therapeutic for the Treatment of Mild-to-Moderate COVID-19
Industry News
April 15, 2021
Merck to Discontinue Development of MK-7110 for COVID-19
Editor´s Pick
April 15, 2021
Ikena Oncology Appoints Dr. Maria Koehler to its Board of Directors
Look Who’s On the Move!
April 15, 2021
Late-Breaking New Independent Validation Study of 1,674 Patients Demonstrates Castle Biosciences' i31-GEP Artificial Intelligence Algorithm Improves Precision of Sentinel Lymph Node Positivity Prediction in...
Editor´s Pick
April 15, 2021
Arrowhead Announces ARO-DUX4 as First Muscle Targeted RNAi Candidate Using TRiMTM Platform
Industry News
April 15, 2021
Dennis H. Langer, M.D., J.D. to Join the Board of Directors of Brooklyn ImmunoTherapeutics, Inc.
Look Who’s On the Move!
April 15, 2021
InterVenn Biosciences Announces that Nobel Laureate James P. Allison, PhD, has Joined the Company’s Board of Advisors
Look Who’s On the Move!
April 15, 2021
Tallac Therapeutics Appoints Curtis Hecht as Chief Business Officer
Look Who’s On the Move!
April 15, 2021
InterVenn Biosciences Announces that Padmanee Sharma, MD, PhD, has Joined the Company’s Board of Advisors
Look Who’s On the Move!
April 15, 2021
CERo Therapeutics Expands Leadership Team with Experts in Cell Therapy Development
Look Who’s On the Move!
April 15, 2021
U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer
Regulatory Affairs
April 14, 2021
TILT Biotherapeutics and MSD to Collaborate on Clinical Trial of Adenoviral Cancer Immunotherapeutic TILT-123 in Combination with KEYTRUDA® (pembrolizumab) for Ovarian Cancer
Clinical Trials
April 14, 2021
